CYP24A1 and metabolic dysfunction-associated steatotic liver disease: CYP24A1 induces low serum levels of 25(OH)D3, which has been shown with liver disease severity in studies with non-alcoholic fatty liver disease (NAFLD) [14] and patients with hepatitis C (HCV) [15].